Formation of the craniofacial skeleton appears to be far more complex
than previously believed. For example, although both synchondroses
(primary cartilage) and sutures and articulation (secondary cartilage)
undergo endochondral ossification, they have different histological and
biochemical profiles and different intrinsic growth potentials. In
addition, although calvarial and facial bones appear to form by
intramembranous ossification without cartilaginous primordia, we and
other have observed transient expression of some cartilage-characteristic
collagen genes during intramembranous ossification. The cellular and
molecular mechanisms involved in the formation of primary and secondary
cartilages and membranous bones of the craniofacial skeleton have not
been elucidated.
Collagens are crucial structural elements which determine the
physicochemical properties of cartilage and bone. In addition, the genes
encoding types I, II and III collagen may have additional functions in
chondrogenesis that are unrelated to their roles in production of
structural proteins. We have isolated two forms of a1(II) collagen mRNA
produced by alternative splicing of the second exon; which encodes a
cysteine-rich globular domain in the amino-propeptide. These two forms
of alpha1(II) collagen mRNA are differentially expressed during
chondrogenesis. In addition, alternative alpha2(I) and alpha1(III)
collagen transcripts have been identified in cartilage. The cartilage
a2(I) collagen mRNA is generated by transcription initiation from an
alternative promotor, and the conceptual translation product of the mRNA
is completely noncollagenous, indication from an alternative promotor,
and the conceptual translation product of the mRNA is completely
noncollagenous, indicating that it must have an alternative function in
cartilage. The structure of the cartilage-specific type III collagen
mRNA has not been completely determined. However, it is much too small
to encode type III collagen; thus it may also have an alternative
function in cartilage.
In this application, we propose to use in situ hybridization and RNase
protection assays to characterize the developing chick craniofacial
skeleton in terms of the collagen mRNAs known to be important for
chondrogenesis and osteogenesis, including the alternative mRNAs of the
type I, II, and III collagen genes. We will compare the pattern of
collagen gene expression in synchondroses (primary cartilage) and sutures
and articulations (secondary cartilage) with that in the epiphyseal
growth plate, which has been extensively characterized at the molecular
and biochemical levels. We will also identify additional cartilage-
characteristic collagen genes which are transiently expressed in
differentiating calvaria (membranous bones). These experiments will
permit us to further define the molecular mechanisms involved in
endochondral ossification in primary and secondary cartilages and
intramembranous ossification. More importantly, collective data from
this project will form the foundation for a subsequent proposal
regarding: 1) the functional roles of alternative type I, II and III
collagen transcripts during normal and abnormal development of the
craniofacial skeleton; and 2) the role of cartilage-characteristic
collagen genes in intramembranous ossification.
National Institute of Dental and Craniofacial Research
CFDA Code
DUNS Number
042250712
UEI
GM1XX56LEP58
Project Start Date
01-February-1994
Project End Date
31-January-1996
Budget Start Date
01-February-1994
Budget End Date
31-January-1995
Project Funding Information for 1994
Total Funding
$39,955
Direct Costs
$24,500
Indirect Costs
$15,455
Year
Funding IC
FY Total Cost by IC
1994
National Institute of Dental and Craniofacial Research
$39,955
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R03DE010916-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R03DE010916-01
Patents
No Patents information available for 1R03DE010916-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R03DE010916-01
Clinical Studies
No Clinical Studies information available for 1R03DE010916-01
News and More
Related News Releases
No news release information available for 1R03DE010916-01
History
No Historical information available for 1R03DE010916-01
Similar Projects
No Similar Projects information available for 1R03DE010916-01